Literature DB >> 8387843

Uses of heparin.

C N Chesterman, B H Chong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8387843      PMCID： PMC1677350          DOI： 10.1136/bmj.306.6882.871

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

Review 1.  Heparin.

Authors:  J Hirsh
Journal:  N Engl J Med       Date:  1991-05-30       Impact factor: 91.245

2.  Heparin-induced thrombocytopenia: studies with a new low molecular weight heparinoid, Org 10172.

Authors:  B H Chong; F Ismail; J Cade; A S Gallus; S Gordon; C N Chesterman
Journal:  Blood       Date:  1989-05-01       Impact factor: 22.113

3.  The British Society for Haematology Guidelines on the use and monitoring of heparin 1992: second revision. BCSH Haemostasis and Thrombosis Task Force.

Authors:  B T Colvin; T W Barrowcliffe
Journal:  J Clin Pathol       Date:  1993-02       Impact factor: 3.411

4.  Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis.

Authors:  R D Hull; G E Raskob; D Rosenbloom; A A Panju; P Brill-Edwards; J S Ginsberg; J Hirsh; G J Martin; D Green
Journal:  N Engl J Med       Date:  1990-05-03       Impact factor: 91.245

5.  Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. The Thromboprophylaxis Collaborative Group.

Authors:  V V Kakkar; A T Cohen; R A Edmonson; M J Phillips; D J Cooper; S K Das; K T Maher; R M Sanderson; V P Ward; S Kakkar
Journal:  Lancet       Date:  1993-01-30       Impact factor: 79.321

Review 6.  Overview of low molecular weight heparins and heparinoids: basic and clinical aspects.

Authors:  J Hirsh
Journal:  Aust N Z J Med       Date:  1992-10

Review 7.  Orgaran in the prevention of deep vein thrombosis in stroke patients.

Authors:  A G Turpie
Journal:  Haemostasis       Date:  1992

8.  Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement.

Authors:  A Planes; N Vochelle; F Mazas; C Mansat; J Zucman; A Landais; J C Pascariello; D Weill; J Butel
Journal:  Thromb Haemost       Date:  1988-12-22       Impact factor: 5.249

9.  Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism.

Authors:  A Gallus; J Jackaman; J Tillett; W Mills; A Wycherley
Journal:  Lancet       Date:  1986-12-06       Impact factor: 79.321
  9 in total
  3 in total

1.  Some limits to evidence-based medicine: a case study from elective orthopaedics.

Authors:  E Ferlie; M Wood; L Fitzgerald
Journal:  Qual Health Care       Date:  1999-06

2.  Uses of heparin. Withhold in acute ischaemic stroke.

Authors:  R I Lindley; P A Sandercock
Journal:  BMJ       Date:  1993-05-22

3.  Uses of heparin. Ancrod for heparin induced thrombocytopenia.

Authors:  R L Soutar; J S Ginsberg
Journal:  BMJ       Date:  1993-05-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.